Answers are grounded in this paper and cite their sources.
The cancer epigenome is characterised by specific DNA methylation and chromatin modification patterns. The proteins that mediate these changes are encoded by the epigenetics genes here defined as: DNA methyltransferases (DNMT), methyl-CpG-binding domain (MBD) proteins, histone acetyltransferases (HAT), histone deacetylases (HDAC), histone methyltransferases (HMT) and histone demethylases. We review the evidence that these genes can be targeted by mutations and expression changes in human cancers.
No takes yet. Share an insight, caveat, or question.
Miremadi et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: